相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma
Isabel Ben-Batalla et al.
BLOOD (2013)
Targeting the Hepatocyte Growth Factor/c-Met Signaling Pathway in Renal Cell Carcinoma
Lauren C. Harshman et al.
CANCER JOURNAL (2013)
HIF1α and HIF2α independently activate SRC to promote melanoma metastases
Sara C. Hanna et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Hypoxia-inducible Factor-1alpha: Molecular-targeted Therapy for Hepatocellular Carcinoma
Z. Dong et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
First Axl inhibitor enters clinical trials
Cormac Sheridan
NATURE BIOTECHNOLOGY (2013)
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
Sakari Vanharanta et al.
NATURE MEDICINE (2013)
A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition
Kevin Wei et al.
NATURE MEDICINE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
CELL (2012)
Axl is essential for VEGF-A-dependent activation of PI3K/Akt
Guo-Xiang Ruan et al.
EMBO JOURNAL (2012)
Pathways and targets in hepatocellular carcinoma
Amanda Psyrri et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Treatment selection in metastatic renal cell carcinoma: expert consensus
Bernard Escudier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
HIF1 alpha and HIF2 alpha: sibling rivalry in hypoxic tumour growth and progression
Brian Keith et al.
NATURE REVIEWS CANCER (2012)
HGF-independent potentiation of EGFR action by c-Met
A. M. Dulak et al.
ONCOGENE (2011)
A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma
Natsuko Suwaki et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6
Sonja Loges et al.
BLOOD (2010)
AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
Erinn B. Rankin et al.
CANCER RESEARCH (2010)
Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors
Rachel Ma Linger et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1 alpha Enhances Hypoxic Gene Expression and Tumor Growth
Adam J. Krieg et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Differential Expression of Axl and Gas6 in Renal Cell Carcinoma Reflecting Tumor Advancement and Survival
Anna Gustafsson et al.
CLINICAL CANCER RESEARCH (2009)
Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma
Anna Gustafsson et al.
PLOS ONE (2009)
Inactivation of von Hippel-Lindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma
N Nakaigawa et al.
CANCER RESEARCH (2006)
Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL
P Staller et al.
NATURE (2003)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
分享论文
